Inform Genomics Transplant Product Shown to Predict Oral Mucositis with a High Degree of Accuracy in Patients Undergoing Conditioning Regimens Prior to Hematopoetic Stem Cell Transplant Boston, MA, Dec. 11, 2012 (GLOBE NEWSWIRE) --  Inform Genomics, Inc., a private company focused on developing novel platforms of genomic-based personalized medicine products for cancer supportive...

Inform Genomics Presents Results For OnPART(tm) Showing High Degree Of Accuracy Predicting Six Common Side Effects Of Dose Dense Chemotherapy Boston, MA, Dec. 6, 2012 (GLOBE NEWSWIRE) --  Inform Genomics, Inc., a private company focused on developing novel platforms of genomic-based personalized medicine products for cancer supportive...

Inform Genomics Announces Positive Top-Line Results in First Phase of Development for OnPART(TM) Personalized Medicine Product Boston, MA, Oct. 1, 2012 (GLOBE NEWSWIRE) -- Inform Genomics, Inc., a private company focused on developing novel platforms of genomic-based personalized medicine products for cancer supportive care...